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Abstract 
We have previously shown that lymphocytic ells adhere to cultured syncytiotrophoblast nd that this may be important in the 
lymphocyte-mediated infection of trophoblast with the human immunodeficiency virus (HIV). During the course of studies aimed at 
investigating the role of cell surface carbohydrates in adhesion, it was discovered that a contaminant of commercial fucose-l-phosphate, 
dicyclohexylamine, inhibited MOLT-trophoblast adhesion. Dicyclohexylamine and the related compounds, cyclohexylamine and hexy- 
lamine, inhibited adhesion in a dose-responsive manner with half-maximal inhibition seen at about 4 mM. While the pressor effects of 
cyclohexylamine, the principal metabolite of cyclamate, are well known, this is the first report of an effect of this and related compounds 
on cell adhesion activity. The inhibitory effect was reversible and, at concentrations less than 25 mM, did not result in loss of cell 
viability. Several possible mechanisms of action of cyclohexylamine w re examined in an attempt o explain the effect on adhesion. No 
evidence was found to suggest that the effects of cyclohexylamine w re due to inhibition of polyamine synthesis, increase in intracellular 
Ca 2+ concentration or to ~t lysosomotropic effect. The concentrations of cyclohexylamine used are within the range of plasma 
concentrations attainable in humans, raising the possibility that the in vitro effects described here may also occur in vivo. The results also 
suggest hat caution should be used in the interpretation of results obtained from experiments where cell adhesion is blocked using 
exogenous monosaccharides that are in the form of dicyclohexylammonium salts. Appropriate controls must be included or, if possible, 
sodium, potassium or barium salts should be chosen. 
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1. Introduction 
We have previously demonstrated that lymphocytic cells 
adhere to human syncytiotrophoblast cultures in a time-de- 
pendent manner [1]. These experiments also showed that 
adhesion was Ca 2+- and Mg:+-dependent and temperature 
sensitive. We recently reported that adhesion was partly 
mediated through lymphocyte VLA-4 (a4  integrin) and an 
as yet unidentified counter-receptor on trophoblast [2]. The 
adhesion of lymphocytes to syncytiotrophoblast may have 
important physiological and immunological consequences 
and may be an important event in the lymphocyte-media- 
ted infection of trophoblast with HIV [1,3]. 
Many adhesion molecules are glycoproteins and in sev- 
eral instances adhesion requires the expression of specific 
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cell-surface carbohydrate moieties that serve as ligands for 
adhesion molecules. Much information about the nature of 
the carbohydrates that are involved has come from studies 
that examine the blocking effects of exogenous carbo- 
hydrates on cell-cell adhesion [4-6]. Most commercially 
available phosphorylated monosaccharides that are used as 
blocking reagents are offered as sodium, barium or potas- 
sium salts. Some, however, are also available, or are only 
available, as dicyclohexylammonium salts. During the 
course of studies aimed at characterizing the role of cell 
surface carbohydrates in the attachment of lymphocytes to 
human trophoblast cells, it was fortuitously discovered that 
adhesion could be inhibited by dicyclohexylamine and, 
subsequently, by cyclohexylamine. These findings are re- 
ported and discussed here. The implications of these re- 
sults for the interpretation of carbohydrate blocking experi- 
ments are also discussed. 
Cyclohexylamine is the principal metabolite of the arti- 
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ficial sweetener, cyclamate [7]. It is well established that 
cyclohexylamine acts as a sympathomimetic amine caus- 
ing the release of noradrenaline and so indirectly increas- 
ing blood pressure in both laboratory animals and in 
humans [8-11]. Cyclohexylamine is also reported to cause 
testicular atrophy in rats [12-14]. Other less well known 
effects of cyclohexylamine include its ability to inhibit 
polyamine synthesis [15,16] and to act synergistically with 
phorbol ester to inhibit metabolic ooperation [17]. To our 
knowledge, there have been no previous reports of the 
effects of cyclohexylamine on cell adhesion events. 
For cell-cell adhesion studies trophoblast cells were 
plated into 96-well culture dishes (Costar) and maintained 
in an air/CO 2 incubator at 37 ° C. Plating efficiency was 
usually about 85% and cell numbers were adjusted so that 
the final plating density was about 300000 cells/cm 2. 
Cellular protein content was determined using a modified 
Lowry assay containing SDS in the alkaline copper eagent 
[21]. Using this assay, 2.5. 10 6 trophoblast cells were 
found to be equivalent to 1 mg protein. 
2.3. MOLT-4 / clone 8 cells 
2. Materials and methods 
2.1. Materials 
Calcein-AM was obtained from Molecular Probes, Eu- 
gene, OR, and stored as a 1 mM stock solution in DMSO 
at -70  ° C. Fura-2-AM was also obtained from Molecular 
Probes and stored as a 3.7 mM solution in DMSO at 
-70°C.  Human recombinant tumor necrosis factor-a 
(TNF-o~; 2" 10 7 units/mg) was purchased from Genzyme 
Corporation, Cambridge, MA. Phosphorylated monosac- 
charides, neutral monosaccharides, fucoidan, mannan, 
chondroitin sulfate and dextran sulfate were obtained from 
Sigma Chemicals, St. Louis, MO. Phosphorylated 
monosaccharides were obtained as barium, sodium or dicy- 
clohexylammonium salts as indicated in the text. Swainso- 
nine, 1-deoxynojirimycin, castonospermine and 1-de- 
oxymannojirimycin were also purchased from Sigma. Neu- 
raminidases from Vibrio cholerae and Arhrobacter ure- 
afaciens were also obtained from Sigma. Dicyclohexy- 
lamine, cyclohexylamine phosphate and hexylamine were 
obtained from Sigma. Chloride forms of dicyclohexy- 
lamine and hexylamine were prepared by reaction with 11 
M HCI followed by acetone precipitation. Spermine and 
spermidine were obtained from Sigma. Monensin was 
obtained from Calbiochem, San Diego, CA and stored as a 
1 mM stock solution in ethanol at 4 ° C. The pH of all 
solutions was routinely checked and adjusted to 7.4 if 
necessary. 
2.2. Trophoblast isolation and primary culture 
A detailed escription of the procedure used to isolate 
and characterize cytotrophoblast ceils from term human 
placentas has been given previously [18]. 
The experiments described here were performed using 
syncytiotrophoblast cells. The culture conditions used to 
induce the differentiation f cytotrophoblast to syncytiotro- 
phoblast have been described elsewhere [19]. Cells were 
generally used 2 days after plating at which time more 
than 90% of the colonies consisted of multinucleated cells 
as determined by anti-desmosome/antinuclear antibody 
immunocytochemistry [19,20]. 
The lymphocytic MOLT-4/clone 8 cell line was ob- 
tained through the AIDS Research and Reference Reagent 
Program, Division of AIDS, NIAID, NIH, and maintained 
in RPMI-1640 containing 20% heat-inactivated fetal calf 
serum. Cells were used for up to 10 passages after which 
cultures were reestablished from the frozen stock. This was 
necessary because the cells began to lose their ability to 
bind to trophoblast after more than about 12 passages. 
2.4. Cell-cell adhesion assay 
A fluorescence-based assay was used in which the 
MOLT cells were labelled with calcein-AM and then 
incubated with syncytiotrophoblast cultures for 1 h at 
37 ° C. The labelling and assay methods have been de- 
scribed in detail previously [1,2]. The trophoblast cultures 
were incubated with TNF-ol (200 U/ml)  for 3 h and then 
washed before addition of the MOLT cells [2]. Culture 
dishes were read in a CytoFluor 2300 fluorescence plate 
reader (Millipore Corporation, Marlborough, MA) using 
485/22 nm excitation and 530/25 nm emission filters. 
Results were calculated as arbitrary fluorescence units/mg 
trophoblast cell protein. 
2.5. Adhesion blocking experiments 
For initial screening studies, calcein-AM-labelled 
MOLT cells were incubated with trophoblast cultures in 
the presence of the compound of interest. Concentrations 
used are given in the figure legends and text. In other 
experiments, either MOLT cells or trophoblast cultures 
were preincubated with the compound of interest for 30 
min at 37 ° C, then washed for different periods of time 
before performing the adhesion assay. We also attempted 
to block adhesion by pretreating cells with neuraminidases 
from Vibrio cholerae and Arthrobacter ureafaciens [22,23] 
and by pretreating cultures with various inhibitors of 
glycoprotein processing (swainsonine, i-deoxynojirimycin, 
castonospermine or 1-deoxymannojirimycin) [24]. 
2.6. Measurement of intracellular Ca 2 + 
Intracellular calcium levels in MOLT cells were deter- 
mined using a Hitachi F-2000 spectrofluorimeter after 
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labelling the cells with a 7.5 /zM concentration of the 
fluorescent calcium probe Fura2-AM [25]. 
2.7. Assessment of  viability 
For all experiments, parallel trophoblast cultures were 
treated with carbohydrates, inhibitors or enzymes as de- 
scribed above but without the addition of MOLT cells. At 
the end of the experiment, protein determinations were 
performed on these cultures to determine whether treat- 
ments caused cell detachment. Viability of both tro- 
phoblast cells and MOLT cells was also assessed by 
Trypan blue staining before and after cells were treated 
with carbohydrates or inhibitors. Because several of the 
compounds used in these studies had to be dissolved in 
either DMSO or ethanol, controls were always included to 
test the effects of these solvents alone. No loss of viability 
was observed at the solvent concentrations u ed for experi- 
ments. 
2.8. Treatment of  results 
All experiments were performed at least three times and 
within an experiment at least triplicate measurements were 
made. Each experiment used cells from a different pla- 
centa. Data were analyzed using InStat software (Graph 
Pad Software, San Diego, CA). 
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3. Results 
3.1. Effect of  cyclohexylamine on adhesion 
The effects of cyclohexylamine were only discovered 
after several experiments had been carried out using vari- 
ous commercial phosphorylated monosaccharides. For 
these experiments, calcein-labelled MOLT cells were incu- 
bated with trophoblast cultures in the presence of different 
carbohydrates and adhesion was measured. The monosac- 
charides used included glucose-l-phosphate, galactose-1- 
phosphate, mannose-l-phosphate, mannose-6-phosphate, 
fucose- 1-phosphate, fructose- 1-phosphate, lactose- 1-phos- 
phate, fucose, and mannose. Of the monosaccharides tested, 
only fucose-l-phosphate appeared to cause a significant 
dose-dependent i hibition of adhesion with a half-maximal 
inhibitory dose of about 3.5 mM (Fig. 1A). With the 
exception of fucose-1-phosphate, which was only available 
as a dicyclohexylammonium salt, the other monosaccha- 
rides were either sodium or barium salts. This raised the 
suspicion that the blockin;g effect might be due to dicyclo- 
hexylamine and not to the sugar itself. This was substanti- 
ated when further experiments were performed with the 
dicyclohexylammonium form of fructose- 1-phosphate. This 
compound inhibited adhesion with a half-maximal in- 
hibitory dose of 3.8 mM, whereas the sodium form had no 
effect (Fig. 1B,C). Unfo~:unately, attempts to convert the 
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Fig. 1. Effect of different forms of fucose-l-phosphate nd fructose-l- 
phosphate on adhesion. Calcein-labelled MOLT cells were incubated in
the presence of the dicyclohexylammonium salt of fucose-l-phosphate 
(A), the dicyclohexylammonium salt of fructose-l-phosphate (B) or the 
sodium salt of fructose-l-phosphate (C) for 30 min at 37 ° C. The cells 
were then added to adherent trophoblast cultures and incubated (still in 
the presence of the indicated compounds) for 1 h, after which adhesion 
was measured as described in Section 2. Results are expressed as % of 
untreated control and represent mean values +S.D. from 3 separate 
experiments. 
dicyclohexylammonium form of fucose-l-phosphate to a 
barium or sodium form using a cation exchange resin were 
unsuccessful. The effects of dicyclohexylamine, and of the 
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related compounds cyclohexylamine and hexylamine, were 
then studied directly. The dose-response curves show that 
each of these amines inhibited the adhesion of MOLT cells 
to trophoblast cultures (Fig. 2A-C).  Concentrations giving 
half maximal inhibition were 5 mM, 4 mM and 2.5 mM 
for dicyclohexylamine, cyclohexylamine and hexylamine, 
respectively. At concentrations of 10 mM and less, cyclo- 
hexylamine had no effect on trophoblast viability or attach- 
ment to the culture dish although some cytoplasmic vac- 
uolization was seen. At concentrations of 25 mM and 
above, cytoplasmic vacuolization and some detachment of 
cells was noticed (Fig. 2). 
In an attempt to determine whether cyclohexylamine 
was affecting MOLT cells or trophoblast or both, experi- 
ments were performed in which MOLT cells or trophoblast 
cells were incubated separately with cyclohexylamine and 
then washed before measuring adhesion. Preincubation of 
trophoblast cells with the amine for 30 min followed by 
rapid washing had no effect on adhesion, whereas preincu- 
bation of MOLT cells resulted in a 30% reduction in 
subsequent adhesion. The effect on MOLT cells was re- 
versible since preincubation with cyclohexylamine fol- 
lowed by a long 30-min wash in fresh medium resulted in 
recovery of most of the adhesion activity. Identical results 
were obtained with dicyclohexylamine (r sults not shown). 
Thus, cyclohexylamine exerted its effect primarily on lym- 
phocytes and not on trophoblast cells. However, it should 
be noted that exposure of trophoblast cultures to high 
concentrations of cyclohexylamine (> 10 raM) did cause 
cytoplasmic vacuolization and on extended exposure (> 4 
h) did cause some cells to detach from the dish (results not 
shown). 
It should be noted that other carbohydrates, including 
chondroitin sulfate (0.5-250 p~g/ml), dextran sulfate 
(0.5-250 /zg/ml), mannan (0.5-250 /~g/ml), fucose 
(0.5-250 mM) and fucoidan (0 .5-250/zg/ml) ,  were with- 
out significant effect on MOLT adhesion or trophoblast 
attachment at all concentrations tested. Adhesion was not 
significantly affected by treatment of trophoblast cells or 
MOLT cells with neuraminidases or by preincubating tro- 
phoblast cultures or MOLT cells for 24 h with inhibitors of 
carbohydrate processing (swainsonine, 1-deoxynojirimy- 
cin, castonospermine or 1-deoxymannojirimycin) (results 
not shown). 
3.2. Mechanism of action of cyclohexylamine on adhesion 
The possibility that the inhibitory effect was the result 
of a cyclohexylamine-dependent inhibition of polyamine 
synthesis [16,26] was investigated. The results showed that 
the inhibitory effect of cyclohexylamine (5 mM) was not 
abrogated by either spermine or spermidine (each at 10 
mM) which would have been expected if inhibition of 
polyamine synthesis was involved. Next, we found that 
intracellular Ca 2÷ levels in MOLT cells incubated with 10 
mM cyclohexylamine were not significantly different from 
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Fig. 2. Effect of different amines on adhesion. Calcein-labelled MOLT 
cells were incubated in the presence of dicyclohexylamine (A), cyclo- 
hexylamine (B) or hexylamine (C) for 30 min at 37 ° C. The cells were 
then added to adherent trophoblast cultures and incubated (still in the 
presence of the indicated compounds) for 1 h, after which adhesion was 
measured as described in Section 2. Results are expressed as % of 
untreated control and represent mean values+S.D, from 3 separate 
experiments. 
untreated controls, ruling out this mechanism of action 
[17]. 
The possibility that cyclohexylamine was operating as a 
lysosomotropic agent was tested by comparing its effects 
to those of the weak bases methylamine and choroquine 
which, like many other amines, are known to accumulate 
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in acidic intracellular compartments and perturb intracom- 
partmental pH gradients [27]. Methylamine inhibited 
MOLT-trophoblast adhesion in a dose-dependent manner 
with an IC50 of 4 mM, while chloroquine had no effect. 
The ionophore monensin, which also perturbs intracellular 
pH gradients, but by a different mechanism, also had no 
significant effect on adhesion (results not shown). 
4. Discussion 
We have previously demonstrated that lymphocytic cells 
adhere to human syncytiotrophoblast cultures in a time-de- 
pendent manner [I]. These experiments also showed that 
adhesion was Ca 2+- and Mge+-dependent and tempera- 
ture-sensitive. We recently reported that adhesion was 
partly mediated through lymphocyte VLA-4 (a4  integrin) 
and an as yet unidentified counter-receptor on trophoblast 
[2]. The present experiments were started with the objec- 
tive of determining whether cell-surface carbohydrates 
played a role in the adhe,;ion process. However, it quickly 
became apparent that the inhibitory effects of certain phos- 
phorylated monosaccharides were due to the dicyclohexy- 
lamine that was present in these preparations. The other 
experiments hown here confirm that the related com- 
pounds, cyclohexylamine and hexylamine, also inhibit ad- 
hesion in a dose-dependent manner. To our knowledge 
these findings are the first to demonstrate an effect of 
cyclohexylamine, the major metabolite of the artificial 
sweetener cyclamate, on cell-cell adhesion. Previous tud- 
ies have shown that cycl:ohexylamine inhibits polyamine 
synthesis [15,16] and acts synergistically with phorbol 
ester to inhibit metabolic ooperation [17]. The concentra- 
tions of cyclohexylamine that were effective in our studies 
were within the range fotmd to be effective in these other 
systems and within the range of attainable plasma concen- 
trations in humans [11]. On the basis of the in vitro results 
presented here, it is possible that cyclohexylamine could 
exert similar effects in vivo. However, the physiological 
consequences of such art effect remain to be explored. 
Cell-cell adhesion plays an important role in the control of 
normal leukocyte trafficking and is also important in 
pathological processes uch as inflammation and tumor 
metastasis [28-30]. 
The mechanism by w)hich cyclohexylamine might in- 
hibit adhesion was also investigated. Our results indicate 
that inhibition of adhesion was not caused by cyclohexy- 
lamine-mediated inhibition of polyamine synthesis [15,16] 
or changes in intracellular Ca 2÷ levels [17] and was proba- 
bly not the result of a lysosomotropic effect. In conclusion, 
further studies will be required to elucidate the mechanism 
of action of cyclohexylarnine on adhesion. 
The corollary of the results reported here is that the data 
do not provide evidence for the involvement of cell-surface 
carbohydrates in MOLT-trophoblast adhesion. In addition 
to the lack of any demonszrable effect of exogenous carbo- 
hydrates, adhesion was unaffected by pretreatment of tro- 
phoblast or MOLT cells with neuraminidase or various 
inhibitors of glycoprotein processing, consistent with little 
or no role for surface carbohydrates in this adhesion 
system. These findings are surprising since we have previ- 
ously shown that the glycosylated integrin, VLA-4, is 
involved in lymphocyte-trophoblast adhesion [2]. Clearly, 
further studies are required to clarify the involvement of 
carbohydrate moieties in this adhesion system. 
Finally, the inhibitory effects of dicyclohexylammo- 
nium forms of monosaccharides have important implica- 
tions for others who may employ such compounds as 
adhesion-blocking reagents. Caution must be used in the 
interpretation of experiments where such compounds are 
used. For example, it has been reported that commercial 
fucose-l-phosphate r duced the binding of CD23-1ipo- 
somes to RPMI-8226 ceils (a B-lymphocytic cell line) and 
this information was used to substantiate he conclusion 
that a cell-surface fucose-1-phosphate moiety was involved 
in the adhesion reaction [31]. Since all commercially avail- 
able fucose-l-phosphate is, to our knowledge, only avail- 
able as a dicyclohexylammonium saltand since appropri- 
ate controls were not described, this conclusion might not 
be valid. Fructose-l-phosphate, mannose-l-phosphate nd 
glucose-l-phosphate are commercially available as dicy- 
clohexylammonium salts but, unlike fucose-l-phosphate, 
are also available in other forms. Clearly, sodium, potas- 
sium or barium salts should be selected where possible. If 
this is not possible, as is the case for fucose-l-phosphate, 
then controls hould be included to exclude artifacts. 
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